IRADIMED CORP Quarterly Income Tax Expense (Benefit) in USD from Q2 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Iradimed Corp quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2013 to Q3 2024.
  • Iradimed Corp Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $1.37M, a 2.05% increase year-over-year.
  • Iradimed Corp Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $4.99M, a 12.5% increase year-over-year.
  • Iradimed Corp annual Income Tax Expense (Benefit) for 2023 was $4.55M, a 35.6% increase from 2022.
  • Iradimed Corp annual Income Tax Expense (Benefit) for 2022 was $3.35M, a 556% increase from 2021.
  • Iradimed Corp annual Income Tax Expense (Benefit) for 2021 was $511K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $4.99M $1.37M +$27.5K +2.05% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $4.96M $1.37M +$249K +22.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $4.71M $1.11M +$163K +17.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $4.55M $1.14M +$112K +10.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-01
Q3 2023 $4.43M $1.34M +$531K +65.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 $3.9M $1.12M +$180K +19.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $3.72M $944K +$370K +64.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $3.35M $1.03M +$1.81M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-01
Q3 2022 $1.54M $810K +$293K +56.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $1.25M $939K +$551K +142% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $700K $573K +$189K +49.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $511K -$779K -$806K -2973% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-02
Q3 2021 $1.32M $518K +$798K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $519K $388K +$1.19M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 -$668K $384K +$1.32M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 -$1.99M $27.1K +$915K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-04
Q3 2020 -$2.9M -$281K -$455K -261% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 -$2.45M -$799K -$1.16M -319% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 -$1.28M -$933K -$694K -290% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 -$588K -$888K -$1.06M -625% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-04
Q3 2019 $469K $174K +$1.08M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 -$615K $365K +$16.6K +4.77% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$631K -$239K -$525K -184% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$106K $169K -$679K -80.1% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-05
Q3 2018 $573K -$910K -$942K -2909% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $1.52M $348K +$357K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $1.16M $286K +$262K +1069% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $897K $848K +$474K +127% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-06
Q3 2017 $423K $32.4K -$997K -96.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $1.42M -$8.36K -$1.11M -101% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $2.53M $24.5K -$1.21M -98% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $3.74M $374K -$537K -58.9% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-07
Q3 2016 $4.28M $1.03M -$371K -26.5% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-06
Q2 2016 $4.65M $1.1M +$135K +13.9% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-04
Q1 2016 $4.51M $1.23M +$407K +49.4% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q4 2015 $4.1M $911K +$1.01M Oct 1, 2015 Dec 31, 2015 10-K 2018-03-08
Q3 2015 $3.09M $1.4M +$1.24M +774% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 $1.85M $969K +$366K +60.8% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $1.49M $824K +$520K +171% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 $967K -$100K Oct 1, 2014 Dec 31, 2014 10-K 2017-03-10
Q3 2014 $160K +$46.2K +40.5% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-10
Q2 2014 $603K +$359K +147% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-11
Q1 2014 $304K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q3 2013 $114K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 $244K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.